New options in the management of intractable ALK(+) metastatic non-small-cell lung cancer
{{output}}
Non-small-cell lung cancer (NSCLC) is a heterogeneous disease and a challenging malignancy to treat, as many patients have advanced disease at the time of diagnosis. Recent advances have led to the identification of molecularly defined subtypes of NSCLC, namel... ...